Third Harmonic Bio Inc THRD:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
18.97quote price arrow up+0.13 (+0.69%)
Volume
73,411
52 week range
16.00 - 21.49
Loading...
  • Open18.60
  • Day High19.74
  • Day Low18.55
  • Prev Close18.84
  • 52 Week High21.49
  • 52 Week High Date09/15/22
  • 52 Week Low16.00
  • 52 Week Low Date09/19/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open18.60
  • Day High19.74
  • Day Low18.55
  • Prev Close18.84
  • 52 Week High21.49
  • 52 Week High Date09/15/22
  • 52 Week Low16.00
  • 52 Week Low Date09/19/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Third Harmonic Bio Inc

 

Profile

MORE
Third Harmonic Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of medicine for the treatment of allergic and inflammatory diseases. Its lead product candidate, THB001, is a potent and highly selective, oral small molecule wild-type KIT inhibitor in development for the treatment of mast cell-mediated inflammatory diseases. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells....
Natalie Holles
Chief Executive Officer, Director
Robert Ho
Chief Financial Officer
Address
300 Technology Square, 8th Floor
Cambridge, MA
02139
United States